 |
| Enter Our Monthly Contest! |
|
Each month, a single Customized Technology Services
(CTS) test will be given away at random.
Enter Now!
|
|
| |
|
PRESS RELEASE
FOR IMMEDIATE RELEASE
CONTACT:
W. Richard Ulmer
(800) 2-INVITRO
http://www.invitrointl.com
INVITRO REPORTS YEAR ENDED FINANCIAL RESULTS
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
Year Ended September 30,
1997 1996
Revenues $720,000 $1,063,000
Costs and expenses 2,077,000 3,036,000
Loss from operations (1,357,000) (1,973,000)
Other income 26,000 74,000
Net loss $(1,331,000) $(1,899,000)
Loss per common share $(0.09) (0.15)
Weighted average common
shares outstanding 14,012,959 12,386,893
Condensed Consolidated Balance Sheet
September 30, September 30,
1997 1996
Cash and cash equivalents $54,000 $1,209,000
Other current assets 584,000 819,000
Total current assets 638,000 2,028,000
Noncurrent assets 255,000 387,000
Total assets $893,000 $2,415,000
Current liabilities $169,000 $351,000
Shareholders' equity 724,000 2,064,000
Total liabilities & equity $893,000 $2,415,000
InVitro International
17751 Sky Park East, Suite G
Irvine, CA 92614
800-2-INVITRO (800-246-8487)
949-851-8356 (International callers)
949- 851-4985 Fax
invitro@invitrointl.com
|
|
